{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:21:34Z","timestamp":1787775694066,"version":"build-2784847793"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>INTRODUCTION:<\/jats:title>\n                    <jats:p>Although systemic heparinization is a widely used technique during digital subtraction angiography (DSA), heparin is associated with a variety of complications including hemorrhage, thrombocytopenia, and hematomas. This study aimed to investigate the safety and efficacy of microdose systemic heparinization or no heparinization on cerebral angiography for cerebrovascular diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>We conducted a prospective, single-blind, randomized controlled study on patients who ought to be experienced cerebrovascular examination and underwent DSA. Participants were randomized into three groups: regular-dose systemic heparinization, microdose systemic heparinization, and no heparinization. Information on patient demographics, laboratory tests, perioperative complications, and back pain scores was collected. Safety endpoints were defined as cerebral ischemic events and local complications of the puncture site. Efficacy endpoints were defined as the recovery of the patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 180 patients were enrolled in the study and randomized into one of three groups. Patients were on average 54.4 \u00b1 10.6 years old and 71.6% were male. Among the three groups, there was no significant difference in the incidence of postoperative thrombotic or ischemic events (regular dose vs. microdose vs. no heparinization: 1.7% vs. 3.3% vs. 1.7%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.774). The microdose or no heparinization group; however, experienced a significantly lower rate of postoperative subcutaneous hematoma (15.0% vs. 3.3% vs. 0%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002), as well as significantly less back pain (21.7% vs. 5.0% vs. 1.7%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) compared to the regular-dose heparinization group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Microdose heparinization or heparin-free cerebral angiography demonstrated similar safety to conventional heparinization but significantly reduced local complications of the puncture site and accelerated recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, identifier NCT06365398.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/bc.bc_41_24","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T03:03:08Z","timestamp":1726196588000},"page":"301-308","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy of low dose or no heparinization in cerebral angiography: A randomized controlled study (SELECT trial)"],"prefix":"10.4103","volume":"11","author":[{"given":"Zheng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Interventional Radiology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichang","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"China International Neuroscience Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinpu","family":"Qin","sequence":"additional","affiliation":[{"name":"China International Neuroscience Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"China International Neuroscience Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"China International Neuroscience Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"R1-20251229","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00234-020-02581-y","article-title":"Evaluation of cerebral arteriovenous shunts:A comparison of parallel imaging time-of-flight magnetic resonance angiography (TOF-MRA) and compressed sensing TOF-MRA to digital subtraction angiography","volume":"63","author":"Sakata","year":"2021","journal-title":"Neuroradiology"},{"key":"R2-20251229","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMcp1605827","article-title":"Subarachnoid hemorrhage","volume":"377","author":"Lawton","year":"2017","journal-title":"N Engl J Med"},{"key":"R3-20251229","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/01.RVI.0000107491.61085.59","article-title":"Cerebral angiography in the assessment of acute cerebral ischemia:Guidelines and recommendations","volume":"15","author":"Barr","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"R4-20251229","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1148\/172.3.1007","article-title":"Heparin in angiography:Current patterns of use","volume":"172","author":"Miller","year":"1989","journal-title":"Radiology"},{"key":"R5-20251229","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2214\/ajr.116.1.204","article-title":"Systemic heparinization for angiography","volume":"116","author":"Wallace","year":"1972","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"Suppl 1","key":"R6-20251229","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.0960-135X.2005.01452.x","article-title":"From heparins to factor Xa inhibitors and beyond","volume":"35","author":"Alban","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"R7-20251229","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0140-6736(12)60409-7","article-title":"Heparin-induced skin lesions","volume":"380","author":"Schindewolf","year":"2012","journal-title":"Lancet"},{"key":"R8-20251229","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants:Antithrombotic therapy and prevention of thrombosis, 9th ed:American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"R9-20251229","first-page":"637","article-title":"Heparin monitoring:Clinical outcome and practical approach","volume":"74","author":"Despas","year":"2016","journal-title":"Ann Biol Clin (Paris)"},{"key":"R10-20251229","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaci.2013.02.047","article-title":"High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy","volume":"132","author":"Schindewolf","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R11-20251229","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bjps.2013.12.027","article-title":"Heparin induced thrombocytopaenia (HIT) as a cause of free flap failure in lower limb trauma","volume":"67","author":"Zaman","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R12-20251229","doi-asserted-by":"crossref","first-page":"9334113","DOI":"10.1155\/2022\/9334113","article-title":"Nursing observation of improved administration route of protamine sulfate neutralizing heparin","volume":"2022","author":"Hu","year":"2022","journal-title":"J Healthc Eng"},{"key":"R13-20251229","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ihj.2012.06.005","article-title":"Our experience of coronary angiography with and without heparin","volume":"64","author":"Datta","year":"2012","journal-title":"Indian Heart J"},{"key":"R15-20251229","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-444-64034-5.00006-7","article-title":"Cerebral angiography:Techniques and practice","volume":"176","author":"Dowd","year":"2021","journal-title":"Handb Clin Neurol"},{"key":"R16-20251229","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MJT.0b013e3181c1218f","article-title":"Comparison of low molecular weight heparin with unfractionated heparin during percutaneous coronary interventions:A meta-analysis","volume":"18","author":"Kodumuri","year":"2011","journal-title":"Am J Ther"},{"key":"R17-20251229","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1055\/s-0040-1715460","article-title":"The anticoagulant and nonanticoagulant properties of heparin","volume":"120","author":"Beurskens","year":"2020","journal-title":"Thromb Haemost"},{"key":"R18-20251229","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1358863X19898253","article-title":"Heparin-induced thrombocytopenia (HIT):Review of incidence, diagnosis, and management","volume":"25","author":"Hogan","year":"2020","journal-title":"Vasc Med"},{"key":"R19-20251229","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"key":"R20-20251229","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.04.009","article-title":"Safety of periprocedural heparin in acute ischemic stroke endovascular therapy:The multi MERCI trial","volume":"21","author":"Nahab","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R21-20251229","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/neurintsurg-2017-013441","article-title":"Periprocedural heparin use in acute ischemic stroke endovascular therapy:The TREVO 2 trial","volume":"10","author":"Winningham","year":"2018","journal-title":"J Neurointerv Surg"},{"key":"R22-20251229","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jvs.2019.01.065","article-title":"The role of heparin in endovascular repair of blunt thoracic aortic injury","volume":"70","author":"Kenel-Pierre","year":"2019","journal-title":"J Vasc Surg"},{"key":"R23-20251229","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/AC.69.6.1000004","article-title":"The REDUCED (a RandomisED stUdy Comparing standard systemic anticoagulation thErapy to low Dose intracoronary anticoagulation therapy for elective percutaneous coronary intervention) trial. A novel pharmacologic regime for elective percutaneous coronary intervention","volume":"69","author":"Ari","year":"2014","journal-title":"Acta Cardiol"},{"key":"R24-20251229","doi-asserted-by":"crossref","first-page":"30733","DOI":"10.1074\/jbc.270.51.30733","article-title":"Internalization of vitronectin-thrombin-antithrombin complex by endothelial cells leads to deposition of the complex into the subendothelial matrix","volume":"270","author":"de Boer","year":"1995","journal-title":"J Biol Chem"},{"key":"R25-20251229","doi-asserted-by":"crossref","first-page":"14151","DOI":"10.1038\/ncomms14151","article-title":"Protein disulfide isomerase secretion following vascular injury initiates a regulatory pathway for thrombus formation","volume":"8","author":"Bowley","year":"2017","journal-title":"Nat Commun"},{"key":"R26-20251229","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1161\/01.CIR.0000144301.82391.85","article-title":"Heparin and air filters reduce embolic events caused by intra-arterial cerebral angiography:A prospective, randomized trial","volume":"110","author":"Bendszus","year":"2004","journal-title":"Circulation"}],"container-title":["Brain Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_41_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:39:13Z","timestamp":1787773153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_41_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/bc.bc_41_24","relation":{},"ISSN":["2394-8108","2455-4626"],"issn-type":[{"value":"2394-8108","type":"print"},{"value":"2455-4626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"2024-05-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}